Article
Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations.
Dementia and geriatric cognitive disorders - 1 Jan 2006
Corbo Rosa Maria, Gambina Giuseppe, Ruggeri Maria, Scacchi Renato
Abstract excerpt
BACKGROUND: Many studies have shown that estrogen replacement therapy may improve cognitive function in women and reduce the risk of Alzheimer's disease (AD). Because most of the estrogen neuroprotective effect is mediated by receptors, we studied the associations between estrogen receptor alpha (ESR1) polymorphisms (PvuII and XbaI) and AD, and their interactions with apolipoprotein E (APOE) polymorphism and...
Topics
Join the communities discussing this publication.
